A Long-term Follow-up Study to Evaluate the Predictive Value of BMS747158 in Patients Suspected of Coronary Artery Disease (CAD)

Withdrawn before enrolling

Conditions studied: Coronary Artery Disease (CAD)

In brief

This long-term study will follow patients with known or suspected of having coronary artery disease (CAD) and have participated in present and future BMS747158 clinical studies. The purpose of this study is to evaluate the long-term predictive value associated with BMS747158 Positron Emission Tomography (PET) Myocardial Perfusion Imaging (MPI).

Key facts

Study ID

NCT01085162

Run by

Lantheus Medical Imaging

People needed

0

Starts

2013-03-01

Expected to finish

2015-03-01

Last updated by the study team

2013-04-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Have known or suspected CAD
• Have participated in a BMS747158 clinical study
• Have received at least 1 dose of BMS747158
• Provide signed informed consent for this study prior to any follow-up contact
• Be capable of communicating effectively with study personnel

You may not qualify if…

• If determined by the Investigator that participation in the study is not in the best interest of the patient or for any sound medical, psychiatric, and/or social reason.

Where it is running

• Cedars-Sinai Medical Center, S. Mark Taper Foundation Imaging Center — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.